Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK Herpes Simplex (gD) Vaccine Phase IIa
NCT00697567Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 1992
- Primary completion
- Dec 1997
- Modality
- Viral Vector Vaccines, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Simplirix in herpes simplex virus infection, sponsored by GSK. Started Sep 1992; status: completed.
02
Drugs
Simplirix
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00697567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697567.